Related Experiment Video

Updated: Mar 2, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K

Effects of Intensive Statin Therapy on Left Ventricular Function in Patients with Myocardial Infarction and Abnormal

Søren Auscher1, Brian Bridal Løgstrup, Jacob Eifer Møller

  • 1Department of Medical Research, OUH/Svendborg Hospital, Svendborg, Denmark.

Cardiology
|May 18, 2017
PubMed

Insights

Intensive statin therapy improved left ventricular function in acute myocardial infarction (AMI) patients. Early high-dose statins showed greater benefits for patients with abnormal glucose tolerance, enhancing recovery after heart attack.

Area of Science:

  • Cardiology
  • Metabolic Disorders

Background:

  • Abnormal glucose tolerance in acute myocardial infarction (AMI) correlates with increased mortality and cardiovascular risks.
  • Statins offer cardiovascular benefits beyond lipid-lowering, including pleiotropic effects.

Purpose of the Study:

  • To investigate the cardioprotective effects of statins on left ventricular (LV) function in AMI patients.
  • To evaluate these effects in relation to the patients' glycometabolic state.

Main Methods:

  • A prospective randomized trial involving 140 AMI patients.
  • Comparison of intensive statin therapy (rosuvastatin loading dose) versus standard statin therapy.
  • Assessment of LV function using speckle-tracking echocardiography to measure regional longitudinal systolic strain (RLSS) in the infarct area and oral glucose tolerance tests.

Main Results:

  • Overall RLSS in the infarct area improved significantly more with intensive statin therapy (-4.22%) compared to usual care (-2.48%) after one month (p=0.047).
  • In patients with abnormal glucose tolerance, RLSS improvement was significantly greater in the intensive statin group (-5.01%) versus the usual care group (-2.15%) (p=0.01).

Conclusions:

  • Early high-dose statin treatment enhances regional systolic function in the infarct area of AMI patients.
  • A trend suggests greater functional improvement with intensive statin therapy in AMI patients with abnormal glucose tolerance.
Abstract

Keywords:
Abnormal glucose toleranceAcute myocardial infarctionIntensive statin therapyLeft ventricular function

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.7K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
741
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
345
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578